West Pharmaceutical Services Inc (NYSE: WST)

West Pharmaceutical Services Inc is a global leader in the design and production of technologically advanced, high-quality containment and delivery systems for injectable drugs and healthcare products. The company operates in the pharmaceutical packaging and drug delivery systems industry, focusing on providing solutions that ensure drug compatibility, stability, and operational efficiency for its customers. West Pharmaceutical Services Inc generates revenue through the sale of a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems. Additionally, the company offers contract manufacturing, analytical lab services, and integrated solutions. Its primary products include stoppers and seals for injectable packaging systems, syringe and cartridge components, administration systems, vials, syringes, plungers, cartridges, and self-injection devices. The company's customer base comprises leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide. The company's business operations are organized into two global business segments, Proprietary Products and Contract-Manufactured Products.
• Proprietary Products Segment: This segment offers elastomers and primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The product portfolio includes stoppers and seals for injectable packaging systems, syringe and cartridge components, administration systems, vials, syringes, plungers, cartridges, and self-injection devices. This segment also provides films, coatings, washing, vision inspection, and sterilization processes and services to enhance the quality of packaging products and mitigate the risk of contamination and compatibility issues. The segment has manufacturing facilities in North and South America, Europe, and Asia, with affiliated companies in Japan and Mexico

• Contract-Manufactured Products Segment: This segment focuses on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The products include a variety of custom contract-manufacturing and assembly solutions, which use technologies such as multi-component molding, in-mold labeling, ultrasonic welding, clean room molding, device assembly, and drug handling capabilities. The segment has manufacturing facilities in North America and Europe
West Pharmaceutical Services Inc competes with several companies across its product lines, including Datwyler and Aptar. The company seeks to differentiate itself by serving as a global supplier of integrated drug containment and delivery systems, offering pre-approval primary packaging support, engineering development, analytical lab services, integrated solutions, regulatory expertise, and after-sale technical support. The company's global manufacturing capability and ability to produce many products at multiple sites are also key competitive advantages. The company's ten largest customers accounted for 47.6% of its consolidated net sales in 2025, with one customer individually accounting for 15.8% or $485.9 million. The general customer base includes leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide.